Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Fulgent Genetics, Inc. Director's Dealing 2022

Aug 3, 2022

32553_dirs_2022-08-03_f8232bde-36e3-4087-8f93-13bbd2bea6f6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2022-08-01

Reporting Person: POST LEONARD E (Director)

More from Fulgent Genetics, Inc.

Regulatory Filings 2026
Jun 1
Regulatory Filings 2026
May 21
Regulatory Filings 2026
May 14
Proxy Solicitation & Information Statement 2026
Mar 31
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Annual Report 2026
Feb 27
Regulatory Filings 2026
Feb 27
View all filings →